BCG vaccine of 2004 the vaccine is given to about 100 million children per year globally. The main use of BCG is for vaccination against tuberculosis. BCG vaccine can be administered after birth intradermally. BCG vaccination can cause a false positive Mantoux test, although a very high-grade reading is usually due to active disease. The most controversial aspect of BCG is the variable efficacy found in different clinical trials, which appears to depend on geography. Trials conducted in the UK have consistently shown a protective effect of 60 to 80%, but those conducted elsewhere have shown no protective effect, and efficacy appears
Inoculation theory regarding the impact of gender on inoculation effectiveness in issue/advocacy campaigns. The conclusion was made that females are more likely to be inoculated with these types of campaigns. An additional observation made by Burgoon et. al (1995) was that the type of content used in these campaigns contributed to the campaigns success. The further the advertisement was from "direct self-benefit" the greater the inoculation effect was on the audience (Burgoon, et al., 1995). It took quite some time for inoculation theory to be applied to marketing, because of the many limitations (Lessne and Didow, 1987). Lessne and Didow (1987) reviewed